Guardion Health Sciences logo
Guardion Health Sciences GHSI
$ 3.25 -0.31%

Quarterly report 2024-Q2
added 08-13-2024

report update icon

Guardion Health Sciences Balance Sheet 2011-2024 | GHSI

Annual Balance Sheet Guardion Health Sciences

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-4.07 M -8.08 M -10.5 M -671 K -4.7 M 8.86 K 758 K - - - -

Long Term Debt

- 3.81 K - - - - - 517 K - - - -

Long Term Debt Current

3.81 K 22.2 K 163 K 152 K - - - - - - - -

Total Non Current Liabilities

- - 272 K 435 K - - - 517 K - - - -

Total Current Liabilities

4.01 M 1.16 M 1.07 M 410 K 495 K 500 K 608 K - - - - -

Total Liabilities

8.52 M 1.16 M 1.35 M 845 K 495 K 500 K 608 K 1.47 M - - - -

Deferred Revenue

- - - - - - - - - - - -

Retained Earnings

-93.7 M -78.8 M -54.1 M -45.5 M -34.6 M -26.9 M -20.7 M -14.1 M - - - -

Total Assets

21.7 M 23.5 M 9.86 M 12.9 M 3.68 M 7.37 M 262 K 246 K - - - -

Cash and Cash Equivalents

10.7 M 4.09 M 8.52 M 11.1 M 671 K 4.74 M 62.5 K 13.8 K - - - -

Book Value

13.2 M 22.3 M 8.52 M 12 M 3.19 M 6.87 M -346 K -1.23 M - - - -

Total Shareholders Equity

7.92 M 22.3 M 8.52 M 12 M 3.19 M - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet Guardion Health Sciences

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - - - - - - - 3.81 K - 186 K 229 K 272 K 272 K 272 K 272 K 435 K 435 K 435 K 435 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - 272 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

1.55 M 6.99 M 3.77 M 5.18 M 6.23 M 5.94 M 8.52 M 1.73 M 1.69 M 1.83 M 1.16 M 1.97 M 1.99 M 1.21 M 1.35 M 1.35 M 1.35 M 1.35 M 845 K 845 K 845 K 845 K 495 K 495 K 495 K 495 K - - - - 608 K - - - 1.47 M - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - 438 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-88 M -98.3 M -93.6 M -94 M -94.4 M -93.2 M -93.7 M -84.8 M -83.1 M -81.4 M -78.8 M -64.3 M -61.3 M -56.7 M -54.1 M -54.1 M -54.1 M -54.1 M -45.5 M -45.5 M -45.5 M -45.5 M -34.6 M -34.6 M -34.6 M -34.6 M -26.9 M -26.9 M -26.9 M -26.9 M -20.7 M -20.7 M -20.7 M -20.7 M -14.1 M - - - - - - - - - - - - - - - - - - -

Total Assets

15.3 M 10.4 M 11.9 M 12.9 M 13.5 M 14.4 M 21.7 M 28.2 M 29.8 M 31.6 M 23.5 M 38.6 M 41.3 M 44.7 M 9.86 M 9.86 M 9.86 M 9.86 M 12.9 M 12.9 M 12.9 M 12.9 M 3.68 M 3.68 M 3.68 M 3.68 M 7.37 M 7.37 M 7.37 M 7.37 M 262 K 262 K 262 K 262 K 246 K - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

14.8 M 5.61 M 6.36 M 7.66 M 8.37 M 8.77 M 10.7 M 12.9 M 4.22 M 4.83 M 4.09 M 3.56 M 5.5 M 43.3 M 8.52 M 8.52 M 8.52 M 8.52 M 11.1 M 11.1 M 11.1 M 11.1 M 671 K 671 K 671 K 671 K 4.74 M 4.74 M 4.74 M 4.74 M 62.5 K 62.5 K 62.5 K 62.5 K 13.8 K - - - 6.16 K - - - - - - - - - - - - - - -

Book Value

13.8 M 3.41 M 8.15 M 7.7 M 7.24 M 8.48 M 13.2 M 26.5 M 28.1 M 29.8 M 22.3 M 36.6 M 39.3 M 43.5 M 8.52 M 8.52 M 8.52 M 8.52 M 12 M 12 M 12 M 12 M 3.19 M 3.19 M 3.19 M 3.19 M 7.37 M 7.37 M 7.37 M 7.37 M -346 K 262 K 262 K 262 K -1.23 M - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

13.8 M 3.41 M 8.15 M 7.7 M 7.24 M 8.48 M 7.92 M 21.3 M 22 M 18.3 M 22.3 M 36.6 M 39.3 M 43.5 M 8.52 M 8.52 M 8.52 M 8.52 M 12 M 12 M 12 M 12 M 3.19 M 3.19 M 3.19 M 3.19 M 6.87 M - 256 K 154 K 346 K - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency